Company: NCEL
Filing Date: 2025-06-06
Form Type: 425
Source: 0001213900-25-052102
Chunk: 1

Company: NewcelX Ltd.
Filing Date: 2025-06-06
Form: 425
Chunk 1
---
 Amount (as defined in the Merger Agreement), and
any adjustments thereto.

In addition, pursuant to the terms of the Fourth Amendment, the Parties clarified that, notwithstanding anything to the contrary contained
in the Merger Agreement, unless the Company has entered into a binding term sheet or a definitive agreement, in either case with respect
to the sale of the Legacy Assets (as defined in the Merger Agreement), or unless otherwise determined by the board of directors of the
Company, the Company shall, beginning on the one-year anniversary of the Closing (as defined in the Merger Agreement), abandon attempts
to consummate the Legacy Sale (as defined in the Merger Agreement) and instead dispose of the Legacy Assets in a manner that it deems
appropriate and expedient.

Finally, the Parties revised the closing conditions to require that the Company shall have convened a shareholder meeting for the election
of the Kadimastem board members as members of the board of the Company, effective as of the Effective Time (as defined in the Merger Agreement),
and such individuals shall have been so elected at such shareholder meeting.

Except
as stated above, the Fourth Amendment does not make any other substantive changes to the Merger Agreement.

The Parties remain focused on and fully committed to aligning their efforts to completing the merger as soon as possible and with the utmost diligence. The Parties are actively working to fulfill all commitments related to the process and adhere to the requirements set forth by all regulatory agents.

Safe Harbor Statement

This
Report of Foreign Private Issuer on Form 6-K contains expressed or implied forward-looking statements pursuant to U.S. Federal securities
laws. For example, the Company and Kadimastem are using forward-looking statements when they discuss the expected completion of the transaction.
These forward-looking statements and their implications are based on the current expectations of the management of the Company and Kadimastem
and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in
the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described
in the forward-looking statements: risks related to the companies’ ability to complete the merger on the proposed terms and schedule,
including risks and uncertainties related to the satisfaction of the closing conditions related to the merger agreement and risks and
uncertainties related to the failure to timely, or at all, obtain shareholder approvals for the transaction; and unexpected costs, charges
or expenses resulting from the transaction and potential adverse reactions